0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Fabry Disease Epidemiology Forecast to 2028
Published Date: February 2019
|
Report Code: DELV-Epid-12
Home | Market Reports | Health | Health Conditions | Genetic Disorders
Fabry Disease  Epidemiology Forecast to 2028

Fabry Disease Epidemiology Forecast to 2028

Code: DELV-Epid-12
Report
February 2019
50 Pages
Delveinsight
Region: North America, Europe,
Description
Table of Content
Tables & Figures

DelveInsight's "Fabry Disease - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Fabry Disease epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Fabry Disease Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Fabry Disease in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Fabry Disease outlook. It also includes the explanation of changing trends of epidemiology outlining the Fabry Disease scenario.

Fabry Disease Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Fabry Disease thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Fabry Disease explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Fabry Disease Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Fabry Disease

Key assessments
• Patient Segmentation in Fabry Disease
• Fabry Disease Risk & Burden
• Factors driving growth in a specific Fabry Disease patient population

1. Report Introduction
2. Fabry Disease Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Fabry Disease in 2016
2.2. Patient Share Distribution of Fabry Disease in 2028
3. Disease Background and Overview: Fabry Disease
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Fabry Disease in 7MM
4.3. Total Prevalent/ Incident Patient Population of Fabry Disease in 7MM – By Countries
5. Epidemiology of Fabry Disease by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Fabry Disease
5.1.3. Sub-Type Specific cases of the Fabry Disease *
5.1.4. Sex- Specific Cases of the Fabry Disease *
5.1.5. Diagnosed Cases of the Fabry Disease
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Fabry Disease
5.4.3. Sub-Type Specific cases of the Fabry Disease *
5.4.4. Sex- Specific Cases of the Fabry Disease *
5.4.5. Diagnosed Cases of the Fabry Disease
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Fabry Disease
5.5.3. Sub-Type Specific cases of the Fabry Disease *
5.5.4. Sex- Specific Cases of the Fabry Disease *
5.5.5. Diagnosed Cases of the Fabry Disease
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Fabry Disease
5.6.3. Sub-Type Specific cases of the Fabry Disease *
5.6.4. Sex- Specific Cases of the Fabry Disease *
5.6.5. Diagnosed Cases of the Fabry Disease
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Fabry Disease
5.7.3. Sub-Type Specific cases of the Fabry Disease *
5.7.4. Sex- Specific Cases of the Fabry Disease *
5.7.5. Diagnosed Cases of the Fabry Disease
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Fabry Disease
5.8.3. Sub-Type Specific cases of the Fabry Disease *
5.8.4. Sex- Specific Cases of the Fabry Disease *
5.8.5. Diagnosed Cases of the Fabry Disease
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Fabry Disease
5.9.3. Sub-Type Specific cases of the Fabry Disease *
5.9.4. Sex- Specific Cases of the Fabry Disease *
5.9.5. Diagnosed Cases of the Fabry Disease
6. Unmet Needs of the Fabry Disease
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Fabry Disease in 7MM
Table 2: Total Prevalent/Incident Cases of the Fabry Disease in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Fabry Disease in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Fabry Disease in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Fabry Disease in United States (2016-2028)*
Table 6: Diagnosed Cases of the Fabry Disease in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Fabry Disease in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Fabry Disease in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Fabry Disease in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Fabry Disease in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Fabry Disease in France (2016-2028)
Table 12: Sub-Type Specific cases of the Fabry Disease in France (2016-2028) *
Table 13: Sex- Specific Cases of the Fabry Disease in France (2016-2028) *
Table 14: Diagnosed Cases of the Fabry Disease in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Fabry Disease in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Fabry Disease in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Fabry Disease in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Fabry Disease in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Fabry Disease in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Fabry Disease in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Fabry Disease in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Fabry Disease in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Fabry Disease in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Fabry Disease in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Fabry Disease in UK (2016-2028) *
Table 26: Diagnosed Cases of the Fabry Disease in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Fabry Disease in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Fabry Disease in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Fabry Disease in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Fabry Disease in Japan (2016-2028)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Fabry Disease in 7MM
Figure 2: Total Prevalent/Incident Cases of the Fabry Disease in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Fabry Disease in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Fabry Disease in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Fabry Disease in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Fabry Disease in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Fabry Disease in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Fabry Disease in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Fabry Disease in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Fabry Disease in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Fabry Disease in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Fabry Disease in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Fabry Disease in France (2016-2028) *
Figure 14: Diagnosed Cases of the Fabry Disease in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Fabry Disease in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Fabry Disease in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Fabry Disease in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Fabry Disease in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Fabry Disease in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Fabry Disease in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Fabry Disease in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Fabry Disease in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Fabry Disease in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Fabry Disease in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Fabry Disease in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Fabry Disease in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Fabry Disease in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Fabry Disease in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Fabry Disease in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Fabry Disease in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools

RELATED REPORTS

Global and Japan Spinal and Bulbar Muscular Atrophy Treatment Market Size Status and Forecast 2021 2027
Global and Japan Spinal and Bulbar Muscular Atrophy Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-24H7799
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global and China Hunter Syndrome Therapeutic Market Insights Forecast to 2027
Global and China Hunter Syndrome Therapeutic Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-22M7919
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global Gene Therapy on Neurological Diseases Market Size Status and Forecast 2021 2027
Global Gene Therapy on Neurological Diseases Market Size, Status and Forecast 2021-2027

In the future this technique may allow doctors to treat a disorder by inserting a gene into a patients cells instead of using drugs or surgery.Market Analysis and Insights Global Gene Therapy on Neurological Diseases MarketIn 2021 the global Gene Therapy on Neurological Diseases market size will be US million and it is expected to reach US million by the end of 2027 with a CAGR of during 20212027.With industrystandard accuracy in analysis and high data integrity the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy on Neurological Diseases market to help players in achieving a strong market position.

120 Pages
Type: Report
Code: QYRE-Auto-25M7562
Tue Sep 21 00:00:00 UTC 2021

Add to Cart

Global and China Y Chromosome Microdeletion Detection Kit Market Insights Forecast to 2027
Global and China Y Chromosome Microdeletion Detection Kit Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-7C7922
Tue Sep 21 00:00:00 UTC 2021

Add to Cart